Opinion|Videos|October 14, 2025

Balancing Treatment Burden, Access Barriers, and Future Research of BCG-Unresponsive NMIBC

An expert discusses how treatment decisions must balance short-term burden with long-term benefits while avoiding protocol-driven step therapy requirements, as future comparative effectiveness trials and real-world evidence will better inform individualized patient care strategies.

Episodes in this series

Newsletter

Get the latest industry news, event updates and more from Managed Healthcare Executive.

Subscribe

Related to this article

Turning provider trust Into a cost conversation
Electronic health record developers, health plans, manufacturers and discount programs could support early prescribing decisions by enabling providers and patients to view more pricing options at the point of prescribing, says Joseph Kleinman, president of Buzz Health.
hospital bed bluish with white dollar signs floating above it | ©ivilianna stock.adobe.com
The Health Care Cost Institute’s annual healthcare cost and utilization report on healthcare spending by those with employer-based health insurance shows that price increases, not utilization, account for soaring cost increases. HCCI CEO Katie Martin says employers should focus on bringing down hospital prices.